Home > Financial Ratios > CIPLA

CIPLA
Working Capital/Sales

    Back to All Ratios
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Working Capital/Sales(x) 2.502.633.033.293.71

What is the latest Working Capital/Sales ratio of CIPLA ?

The latest Working Capital/Sales ratio of CIPLA is 2.50 based on Mar2024 Consolidated results.
Year Working Capital/Sales
Mar20242.50
Mar20232.63
Mar20223.03
Mar20213.29
Mar20203.71

How is Working Capital/Sales of CIPLA Trending?

Years Working Capital/Sales % Change
Mar2024 2.5
-4.94
Mar2023 2.63
-13.20
Mar2022 3.03
-7.90
Mar2021 3.29
-11.32
Mar2020 3.71 -

Other Financial Ratios of CIPLA


Compare Working Capital/Sales ratio of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹121,324.6 Cr -0.1% 0.5% 1.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹404,768.0 Cr 0.4% -1.2% 12.2% Stock Analytics
DIVIS LABORATORIES ₹178,468.0 Cr 2.6% 8.4% 48.5% Stock Analytics
DR REDDYS LABORATORIES ₹113,757.0 Cr 3.2% 11.8% 11.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹110,345.0 Cr 3.4% 0.5% 12.8% Stock Analytics
MANKIND PHARMA ₹98,512.2 Cr 1.4% -6.4% 11.8% Stock Analytics


CIPLA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

-0.1%

0.5%

1.7%

SENSEX

0.3%

0.7%

8.8%


You may also like the below Video Courses